Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00983398

Recruitment Status : Active, not recruiting

First Posted : September 24, 2009

Last Update Posted : October 26, 2021

Sponsor:

Collaborators:

National Institute of Neurological Disorders and Stroke (NINDS)

Oregon Health and Science University

Information provided by (Responsible Party):

Edward Neuwelt, OHSU Knight Cancer Institute

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	December 31, 2021
Estimated Study Completion Date :	December 31, 2022

To Top